My watch list
my.bionity.com  

my.bionity.com

With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

1,4,6-Androstatrien-3,17-dione



1,4,6-Androstatrien-3,17-dione
Systematic (IUPAC) name
(8R,9S,10R,13S,14S)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthrene-3,17-dione
Identifiers
CAS number 633-35-2
ATC code  ?
PubChem 682340
Chemical data
Formula C19H22O2 
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half life Minutes
Excretion  ?
Therapeutic considerations
Pregnancy cat.

X(US)

Legal status

?(US)

Routes Parenteral

1,4,6-Androstatrien-3,17-dione (ATD) is a potent irreversible aromatase inhibitor that inhibits estrogen biosynthesis by permanently binding and inactivating aromatase in adipose and peripheral tissue.[1] It is used to control estrogen synthesis.[2]

ATD is present in some over-the-counter bodybuilding supplements such as Rebound XT, Novedex XT and Inhibit-E. While not banned, ATD may cause positive urinanalysis results leading to disqualification from competitive sports due to its similar properties to banned substances.[3]

A related agent is exemestane (Aromasin).

References

  1. ^ Covey DF, Hood WF. (1981). "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity". Endocrinology 108 (4): 1597-9. PMID 7472286.
  2. ^ Adkins-Regan, Elizabeth; Cary H Leung (2006-07-06). "Sex steroids modulate changes in social and sexual preference during juvenile development in zebra finches". Hormones and Behaviour 50 (5): 772-778. Elsevier Inc. Retrieved on 2007-10-07.
  3. ^ DRUG TESTING (HTML). Organization of Competitive Bodybuilders. Retrieved on 2007-10-07.

Further Reading

  1. ^ Covey DF, Hood WF. (1981). "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity". Endocrinology 108 (4): 1597-9. PMID 7472286.
  2. Ellinwood WE, Hess DL, Roselli CE, Spies HG, Resko JA (1984). "Inhibition of aromatization stimulates luteinizing hormone and testosterone secretion in adult male rhesus monkeys". J. Clin. Endocrinol. Metab. 59 (6): 1088–96. PMID 6541658.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "1,4,6-Androstatrien-3,17-dione". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE